Integration of the proteasome inhibitor PS-341 (Velcade) into the therapeutic approach to lung cancer

This publication has 32 references indexed in Scilit:

• Endoproteolytic Activity of the Proteasome
  Science, 2003
• Development of the Proteasome Inhibitor PS-341
  The Oncologist, 2002
• Molecular–clinical correlative studies in non-small cell lung cancer: application of a three-tiered approach
  Lung Cancer, 2001
• High cyclin E and low p27/Kip1 expressions are potentially poor prognostic factors in lung adenocarcinoma patients
  Lung Cancer, 2001
• Aberrant Expression of pRb, p16, p14ARF, MDM2, p21 and p53 in Squamous Cell Carcinomas of Lung
  Japanese Journal of Cancer Research, 2001
• Protease inhibitor-induced apoptosis: accumulation of wt p53, p21WAF1/CIP1, and induction of apoptosis are independent markers of proteasome inhibition
  Leukemia, 2000
• Proteasome Inhibition: a New Strategy in Cancer Treatment
  Investigational New Drugs, 2000
• Roles of ubiquitin-mediated proteolysis in cell cycle control
  Current Opinion in Cell Biology, 1997
• Proteasome-Dependent Regulation of p21WAF1/CIP1Expression
  Biochemical and Biophysical Research Communications, 1996
• Abnormalities in Structure and Expression of the Human Retinoblastoma Gene in SCLC
  Science, 1988